- Jan 28, 2022
Genetic ancestry provides important context for understanding global diversity in childhood leukemia
St. Jude Children's Research Hospital scientists have shown that addressing racial disparities in acute lymphoblastic leukemia should...
- Jan 27, 2022
Nanoparticle-formulated drug combination is effective in medulloblastoma, a pediatric brain tumor
Researchers have demonstrated that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle...
- Jan 24, 2022
‘Welcome to our world’: families of children with cancer say the pandemic has helped them feel seen
As both the mother of a childhood cancer survivor and a Curtin University PhD student exploring families’ experiences of childhood ...
- Jan 21, 2022
Improving Endocrine Care for Childhood Cancer Survivors
Endocrine issues are some of the most common late effects of cancer treatment. Although 85% of children now survive cancer, studies have...
- Jan 19, 2022
FDA Approves Rare Pediatric Disease Designation for IMX-110 for Rhabdomyosarcoma
Officials with the FDA have approved a Rare Pediatric Disease Designation for IMX-110 for the treatment of pediatric patients with ...
- Jan 5, 2022
Mortality Risk Later in Life May Be Increased in Childhood Leukemia Survivors With Down Syndrome
Patients with Down syndrome have an increased risk for leukemia during childhood, and toxicities related to treatment may be more common...